Literature DB >> 21289152

Imipenem disc for detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice.

Shmuel Benenson1, Violeta Temper, Matan J Cohen, Carmela Schwartz, Carlos Hidalgo-Grass, Colin Block.   

Abstract

The global spread of class A-carbapenemase-producing Enterobacteriaceae has made the development of a simple test a desirable goal. A disc diffusion test using imipenem was 100% sensitive and 96% specific in identifying carbapenemase-producing organisms, potentially reducing or eliminating the need for the relatively labor-intensive modified Hodge test.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289152      PMCID: PMC3122805          DOI: 10.1128/JCM.02179-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species.

Authors:  K Lee; Y Chong; H B Shin; Y A Kim; D Yong; J H Yum
Journal:  Clin Microbiol Infect       Date:  2001-02       Impact factor: 8.067

2.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Authors:  Shiri Navon-Venezia; Azita Leavitt; Mitchell J Schwaber; J Kamile Rasheed; Arjun Srinivasan; Jean B Patel; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

5.  Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Zmira Samra; Judi Bahar; Liora Madar-Shapiro; Nazi Aziz; Sara Israel; Jihad Bishara
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

6.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Authors:  Simona Bratu; David Landman; Robin Haag; Rose Recco; Antonella Eramo; Maqsood Alam; John Quale
Journal:  Arch Intern Med       Date:  2005-06-27

7.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

8.  Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

Authors:  Azita Leavitt; Shiri Navon-Venezia; Inna Chmelnitsky; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Authors:  Alicia I Hidron; Jonathan R Edwards; Jean Patel; Teresa C Horan; Dawn M Sievert; Daniel A Pollock; Scott K Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

10.  Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

Authors:  K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

View more
  4 in total

1.  Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.

Authors:  Athanassios Tsakris; Katerina Themeli-Digalaki; Aggeliki Poulou; Georgia Vrioni; Evangelia Voulgari; Vasiliki Koumaki; Antonella Agodi; Spyros Pournaras; Danai Sofianou
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

2.  Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae.

Authors:  Kathryn M Day; Rachel Pike; Trevor G Winstanley; Clare Lanyon; Stephen P Cummings; Muhammad W Raza; Neil Woodford; John D Perry
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

3.  Occurrence of SHV, TEM and CTX-M β-Lactamase Genes Among Enteropathogenic Escherichia coli Strains Isolated From Children With Diarrhea.

Authors:  Mojtaba Memariani; Shahin Najar Peerayeh; Taghi Zahraei Salehi; Seyyed Khalil Shokouhi Mostafavi
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

4.  Characterization of Plasmid-Mediated AmpC and Carbapenemases among Iranain Nosocomial Isolates of Klebsiella pneumoniae Using Phenotyping and Genotyping Methods.

Authors:  Alireza Japoni-Nejad; Ehsanollah Ghaznavi-Rad; Alex van Belkum
Journal:  Osong Public Health Res Perspect       Date:  2014-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.